Mystic Ventures
VC Fund
Florida, United States
Mystic Ventures is a venture capital firm that specialises in using psychedelics for medical purposes.
- Total investments:
- 32
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries Mystic Ventures invests in
Stages Mystic Ventures invests in
Countries Mystic Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Investment Focus
Industry
- Health Care 16 (50%)
- Biotechnology 8 (25%)
- Medical 5 (16%)
- Wellness 5 (16%)
- Life Science 3 (9%)
Stage
- Seed 17 (53%)
- Pre-Seed 3 (9%)
- Series A 3 (9%)
- Venture - Series Unknown 3 (9%)
- Funding Round 2 (6%)
Country
- United States 21 (66%)
- Canada 2 (6%)
- Costa Rica 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brock Pierce
Managing Partner
|
Managing Partner | Total investments: 13 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Xylo Bio
|
Xylo Bio is a drug development company that focuses on next-generation psychedelics. With psychedelic molecules as the starting point, our goal is to develop medicines that are widely available as improved treatments to currently available SSRI medications. | $8M / Seed / Jun 02, 2024 | |
Psilera
|
Psilera develops therapies aimed at neurological and psychiatric disorders by leveraging neuroplastogens, compounds that promote brain plasticity without hallucinogenic effects. The company builds a proprietary library of serotonergic compounds and applies computational tools to design molecules for conditions such as alcohol use disorder andfrontotemporal dementia. Its research pipeline emphasizes non-hallucinogenic derivatives of psychedelic compounds to provide safe and scalable treatment options. Psilera integrates medicinal chemistry, neuroscience, and pharmacology to create small-molecule drugs that address unmet medical needs. Through this approach, the company seeks to expand treatment possibilities for patients facing hard-to-treat neurological conditions. | $3M / Venture - Series Unknown / Feb 25, 2024 | |
|
Spiritus Bioscience
|
Spiritus Bioscience is a drug development company seeking to apply their proprietary drug-delivery technology to the Medicalized-Psilocybin market in Oregon | Aug 01, 2023 | |
Awakn Life Sciences
|
Awakn Life Sciences is a biotechnology company with clinical operations that develops and delivers psychedelic medicine to better treat addiction. Awakn's team consists of chemists, scientists, psychiatrists, and psychologists who are developing and advancing the next generation of psychedelic drugs, therapies, and enabling technologies totreat addiction. | $2M / Post-IPO Equity / Apr 26, 2023 | |
2A Biosciences
|
2A Biosciences is a pharmaceutical company that develops drugs with small molecules focusing on inflammation using 2A agonists. The company is currently operating in stealth mode. | $136.7K / Seed / Apr 01, 2023 | |
Sama Therapeutics
|
Precision Neuropsychiatry | Pre-Seed / Apr 01, 2023 | |
Heading Health
|
Heading Health is a technology-enabled mental health platform improving access to high-quality and affordable care. Heading delivers personalized treatment solutions that leverage evidence-based therapeutics and technologies such as Spravato, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. | Venture - Series Unknown / Apr 01, 2023 | |
DopaGE
|
DopaGE enables academic institutions to ensure that every student on their campus is educated in overdose prevention and response. Our cloud-based course is easy for institutions to implement and our gamified content keeps students engaged to deliver life-saving results. Overdose is the leading cause of death for GenZ and Millennial Americans -despite being fully preventable. DopaGE is here to change that. | Seed / Mar 30, 2023 | |
|
DopaGE
|
DopaGE enables academic institutions to ensure that every student on their campus is educated in overdose prevention and response. Our cloud-based course is easy for institutions to implement and our gamified content keeps students engaged to deliver life-saving results. Overdose is the leading cause of death for GenZ and Millennial Americans -despite being fully preventable. DopaGE is here to change that. | Pre-Seed / Mar 30, 2023 | |
Journey Clinical
|
Journey Clinical is a platform that provides services to member psychotherapy practices that are independently owned and operated, and in no way owns, directs, or controls the mental healthcare clinicians providing care. | $8.5M / Series A / Jan 24, 2023 | |
| See all 32 investments → | |||
Co-Investors
Tabula Rasa Ventures
4 deals together
Gaingels
3 deals together
PsyMed Ventures
3 deals together
Empath Ventures
2 deals together
M8 Ventures
2 deals together
Palo Santo Fund
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Mystic Ventures invest in?
Mystic Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Pre-Seed stage. Most of the 32 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Mystic Ventures?
Public channels for Mystic Ventures include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Mystic Ventures?
The team at Mystic Ventures includes Brock Pierce (Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
